About US
Contact us
-
China taking closer look at drug prices, cost structureChinese regulators say they will size up the cost structures and pricing of 60 drugmakers, both domestic and foreign, as it figures out what it should be paying for drugs. According toBloomberg, the N2013/7/8
-
Fresenius gets warning letter for India plantFreseniusKabi, the generic drug unit for the German healthcare company, this week received an FDA warning letter for a plant in India. The company said it is dealing with the issues, but its work on t2013/7/8
-
CFDA Vice Minister Liu Peizhi meets the French Foreign Minister's Special Representative for China Affairs and French Ambassador to ChinaOn the morning of July 2, 2013, Liu Peizhi, Vice Minister of China Food and Drug Administration (CFDA) met with the delegation led by Martine Aubry, the French Foreign Minister's Special Representativ2013/7/4
-
CFDA Assistant Minister Bian Zhenjia meets Deputy Minister of Health of VietnamOn June 25, 2013, Bian Zhenjia, Assistant Minister of China Food and Drug Administration (CFDA), met with the delegation led by Mr. Pham Le Tuan, Deputy Minister of Health of Vietnam, and introduced t2013/7/4
-
Sanofi shaves 207 R&D jobs in scaled-back reorgUnder assault from union leaders and government officials, Sanofi ($SNY) was forced to back off plans to engineer a major reorganization of its R&D operations in France. But it's going ahead with2013/7/4
-
Indian drugmakers balk at new Actos banIndian drugmakers are fighting the country's new ban on thediabetes drugpioglitazone, otherwise known asActos. Regulators suspended sales of the drug last week, citing safety worries, including concer2013/7/4
-
Is GlaxoSmithKline's China probe a harbinger of more?Are more drugmakers at risk of corruption probes inChina? After GlaxoSmithKline employees were detained in an investigation of "economic crimes," industry watchers point out that the Chinese governmen2013/7/3
-
FDA slaps a clinical hold on Achillion hep C drugShares of Achillion ($ACHN) skidded down 20% as the FDA put a clinical hold on itshepatitis Cdrug sovaprevir. Investigators had flagged a spike in liver enzymes--a classic sign of toxicity--among a gr2013/7/3
-
Chinese police corral GlaxoSmithKline employees in bribery probeChinese police rounded up GlaxoSmithKline employees in three cities as part of an investigation into "economic crimes," law enforcement there said in a statement. According to as-yet-unconfirmed repor2013/7/2
-
Private equity buyers eye offer for GlaxoSmithKline's drinks brandsPrivate equity firms Blackstone and Lion Capital are together eyeing an offer for GlaxoSmithKline's ($GSK) drinks brands Lucozade and Ribena. Up for sale as the U.K.-based drugmaker sheds lower-perfor2013/7/2